These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Nevada
|
33-0903494
|
|
(State or Other Jurisdiction
|
(IRS Employer
|
|
Of Incorporation)
|
File Number) |
|
9235 Bell Flower Way
|
|
|
Highlands Ranch, CO
|
80126
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Title of each class
|
Name of each exchange on which registered
|
|
Large accelerated filer
|
o |
Accelerated filer
|
o | |
|
Non-accelerated filer
|
o |
Smaller reporting company
|
x | |
| (Do not check if a smaller reporting company) |
|
●
|
Paul Petit, Jean-Phillipe Petit, Alain Petit and Kelly Thompson resigned as officers and/or directors of the Company.
|
|
|
●
|
Paul Petit agreed to the cancellation of 1,175,000 shares of his common stock. These shares were returned to treasury and cancelled.
|
|
|
●
|
S.A.R.L. Naprodis, which is controlled by Alain Petit, sold 1,788,000 shares of the Company’s common stock to the Company for a nominal consideration. The shares sold to the Company were returned to treasury and cancelled.
|
|
|
●
|
The following persons were appointed as officers and directors of the Company:
|
|
Daniel Allen
|
President, Chief Executive Officer and a Director
|
|
|
Chase Zeman
|
Secretary, Treasurer and a Director
|
|
●
|
An LED lighting system that requires 70% less energy than current systems and offers prism based lighting spectrums to provide a software controlled lighting system.
|
|
|
●
|
cartridges and pen constructs that allow licensed dispensaries to distribute e-marijuana cigarette products
|
|
|
●
|
protection and security
|
|
|
●
|
assistance with regulatory compliance
|
|
|
●
|
employment, background checks and other human resource services
|
|
|
●
|
advertising and marketing
|
|
|
●
|
capital and related financial services.
|
|
Name
|
Age
|
Title
|
||
|
Daniel Allen
|
62
|
President, Chief Executive Officer and a Director
|
||
|
Chase Zeman
|
29
|
Secretary, Treasurer and a Director
|
| Stock | Option | All Other | ||||||||||
|
Name and Principal
|
Period
|
Salary
|
Bonus
|
Awards
|
Awards
|
Compensation
|
||||||
|
Position
|
Total
|
(1)
|
(2)
|
(3) |
(4)
|
(5) | ||||||
|
Paul Petit,
|
2014
|
--
|
--
|
--
|
--
|
--
|
||||||
|
President and
|
2013
|
--
|
--
|
--
|
--
|
--
|
||||||
|
Chief Executive
|
||||||||||||
|
Officer
|
||||||||||||
|
Daniel Allen
|
2014
|
--
|
--
|
--
|
--
|
--
|
||||||
|
President (1)
|
|
|||||||||||
|
Chase Zeman
|
2014
|
--
|
--
|
--
|
--
|
--
|
||||||
|
Secretary and
|
|
|||||||||||
|
Treasurer (1)
|
|
|
(1)
|
Mr. Allen and Mr. Zeman were appointed officers of the Company on August 25, 2014.
|
|
|
Shares | |||||||
|
Name of
|
Beneficially
|
Percent of | ||||||
|
Beneficial Owner
|
Owned
|
Class | ||||||
|
Daniel Allen
|
5,000,000 | 33 | % | |||||
|
Chase Zeman
|
5,000,000 | 33 | % | |||||
|
All Executive Officers and
|
||||||||
|
Directors as a group (2 persons)
|
10,000,000 | 66 | % | |||||
|
Travis Hair
|
3,174,600 | 21 | % | |||||
|
Name
|
Date
|
Shares
|
Consideration
|
|||||||||
|
Daniel Allen
|
11-12-14 | 5,000,000 | $ | 63,000 | ||||||||
| Chase Zeman | 11-12-14 | 5,000,000 | $ | 63,000 | ||||||||
|
Travis Hair
|
11-25-14 | 3,174,600 | $ | 40,000 | ||||||||
|
Year Ended August 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Audit Fees
|
$ | 11,000 | $ | 6,500 | ||||
|
Audit-Related Fees
|
-- | -- | ||||||
|
Tax Fees
|
-- | -- | ||||||
|
All Other Fees
|
-- | -- | ||||||
|
Exhibit
Number
|
Exhibit Name |
|
3.1
|
Articles of Incorporation*
|
|
3.2
|
Bylaws*
|
|
*
|
Incorporated by reference to the same exhibit filed with the Company’s registration statement on Form S-1 (File #333-122009)
|
|
NAPRODIS, INC.
|
||||||||
|
|
||||||||
|
August 31,
|
August 31,
|
|||||||
|
|
2014
|
2013
|
||||||
| ASSETS | ||||||||
|
Current Assets
|
||||||||
|
Cash
|
$ | 63,000 | $ | 3,542 | ||||
|
Accounts Receivable
|
- | 22,431 | ||||||
|
Inventories, net
|
- | 19,923 | ||||||
|
Total Current Assets
|
63,000 | 45,896 | ||||||
|
Property and equipment, net
|
- | 25,959 | ||||||
|
Long-term inventories
|
- | 119,534 | ||||||
|
Other Assets
|
- | 10,159 | ||||||
|
TOTAL ASSETS
|
$ | 63,000 | $ | 201,548 | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts Payable and accrued expenses
|
$ | 72,348 | $ | 239,757 | ||||
|
Accrued payroll and payroll taxes
|
2,476 | 1,783 | ||||||
|
Accrued Interest
|
- | 52,517 | ||||||
|
Stock subscription payable
|
63,000 | - | ||||||
|
Customer Deposits
|
- | 2,319 | ||||||
|
Payables to related party
|
- | 139,586 | ||||||
|
Officer Loans
|
- | 216,737 | ||||||
|
Total Liabilities
|
137,824 | 652,699 | ||||||
|
Stockholders' Deficit
|
||||||||
|
Preferred stock, $0.001 par value,
|
||||||||
|
10,000,000 shares authorized, 0 shares issued
|
- | - | ||||||
|
Common Stock, $0.001 par value,
|
||||||||
|
60,000,000 shares authorized;
|
||||||||
|
2,027,000 and 4,990,000 issued and outstanding at
|
||||||||
|
August 31, 2014 and August 31, 2013
|
2,027 | 4,990 | ||||||
|
Additional paid-in capital
|
791,335 | 131,260 | ||||||
|
Deficit
|
(868,186 | ) | (587,401 | ) | ||||
|
Total Stockholders's Deficit
|
(74,824 | ) | (451,151 | ) | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$ | 63,000 | $ | 201,548 | ||||
|
NAPRODIS INC.
|
||||||||
|
|
||||||||
|
August 31,
|
August 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
Revenues
|
$ | - | $ | 207,316 | ||||
|
Cost of sales, (exclusive of depreciation, included in
|
||||||||
|
general & administrative expenses)
|
- | 23,217 | ||||||
|
Gross profit
|
- | 184,099 | ||||||
|
Selling expenses
|
- | 19,027 | ||||||
|
General and administrative expenses
|
||||||||
|
Occupancy costs
|
- | 146,746 | ||||||
|
Salaries and wages
|
- | 9,697 | ||||||
|
Other general and administrative expenses
|
69,837 | 154,029 | ||||||
|
Total general and administrative expenses
|
69,837 | 310,472 | ||||||
|
Net Loss before other income and expenses
|
(69,837 | ) | (145,400 | ) | ||||
|
Interest expense
|
- | (22,195 | ) | |||||
|
Loss on discontinued operations
|
(210,948 | ) | - | |||||
|
Net Income (Loss)
|
$ | (280,785 | ) | $ | (167,595 | ) | ||
|
Net Loss per share - basic and diluted
|
$ | (0.06 | ) | $ | (0.03 | ) | ||
|
Weighted average common shares
|
||||||||
|
outstanding - basic and diluted
|
4,941,458 | 4,990,000 | ||||||
|
NAPRODIS, INC
|
||||||||||||||||||||
|
STATEMENT OF STOCKHOLDERS' DEFICIT
|
||||||||||||||||||||
|
Stockholders'
|
||||||||||||||||||||
|
Additional
|
Equity
|
|||||||||||||||||||
|
Common Stock
|
Paid -in
|
Accumulated
|
(Deficit)
|
|||||||||||||||||
|
Share
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||||
|
Balance at August 31, 2012
|
4,990,000 | 4,990 | 131,260 | (419,806 | ) | (283,556 | ) | |||||||||||||
|
Net loss for the year
|
(167,595 | ) | (167,595 | ) | ||||||||||||||||
|
Balance at August 31, 2013
|
4,990,000 | 4,990 | 131,260 | (587,401 | ) | (451,151 | ) | |||||||||||||
|
Cancellation of owner shares
|
(2,963,000 | ) | (2,963 | ) | 2,963 | - | ||||||||||||||
|
Disposal of operations
|
657,112 | 657,112 | ||||||||||||||||||
|
Net loss for the year
|
(280,785 | ) | (280,785 | ) | ||||||||||||||||
|
Balance at August 31, 2014
|
2,027,000 | 2,027 | 791,335 | (868,186 | ) | (74,824 | ) | |||||||||||||
|
NAPRODIS, INC.
|
||||||||
|
|
||||||||
|
August 31,
|
August 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
Operating Activities
|
||||||||
|
Net loss
|
$ | (280,785 | ) | $ | (167,595 | ) | ||
|
Adjustments to reconcile net loss to net cash used in operations:
|
||||||||
|
Depreciation expense
|
- | 14,564 | ||||||
|
Discontinued operations
|
210,948 | - | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts Receivable
|
- | (11,035 | ) | |||||
|
Inventory
|
- | (21,374 | ) | |||||
|
Prepaid expenses
|
- | - | ||||||
|
Accounts Payable and accrued expenses
|
66,133 | 141,093 | ||||||
|
Accrued payroll and payroll taxes
|
162 | 942 | ||||||
|
Accrued Interest
|
- | 18,722 | ||||||
|
Customer Deposits
|
- | 2,319 | ||||||
|
Stock subscription payable
|
63,000 | - | ||||||
|
Net Cash provided by operating activities
|
59,458 | (22,364 | ) | |||||
|
Financing Activities
|
||||||||
|
Proceeds from officer loans
|
- | 10,195 | ||||||
|
Proceeds (repayment) of payable to related party
|
- | 15,063 | ||||||
|
Cash distributed to related party
|
- | - | ||||||
|
Net Cash provided by financing activities
|
- | 25,258 | ||||||
|
Net Increase (Decrease) in cash
|
59,458 | 2,894 | ||||||
|
Cash, beginning of period
|
3,542 | 648 | ||||||
|
Cash, end of period
|
$ | 63,000 | $ | 3,542 | ||||
|
Supplemental disclosures of cash flow information
|
||||||||
|
Cash paid for
|
||||||||
|
Interest
|
$ | - | $ | - | ||||
|
Income taxes
|
- | - | ||||||
|
Non-cash supplemental disclosures
|
||||||||
|
Cancellation of shares held by previous owners
|
$ | 2,963 | $ | - | ||||
|
Disposal of operations
|
657,112 | |||||||
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities.
|
|
Level 2:
|
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.
|
|
Level 3:
|
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
|
August 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Raw materials
|
$
|
-
|
$
|
56,664
|
||||
|
Work in process
|
-
|
3,246
|
||||||
|
Finished goods
|
-
|
17,526
|
||||||
|
Containers and Packaging
|
-
|
59,072
|
||||||
|
Total inventory
|
-
|
149,417
|
||||||
|
Provision for price adjustments
|
-
|
(9,960
|
)
|
|||||
|
Inventory, net
|
$
|
-
|
$
|
139,457
|
||||
|
Equipment:
|
5 and 7 years (pallet racks 10 years)
|
|
Furniture and Fixtures
|
7 years
|
|
Autos, trucks, buses
|
5 years
|
|
2014
|
2013
|
|||||||
|
Service
|
n/a
|
7.1
|
%
|
|||||
|
Personal Care
|
n/a
|
90.2
|
%
|
|||||
|
Other
|
n/a
|
2.7
|
%
|
|||||
|
August 31,
2014
|
August 31,
2013
|
|||||||
|
Net operating losses
|
277,000
|
235,000
|
||||||
|
Less: valuation allowance
|
(277,000
|
)
|
(235,000
|
)
|
||||
|
Net deferred tax assets
|
$
|
-
|
$
|
-
|
||||
|
Cost
|
Accumulated
Depreciation
|
August 31,
2013
Net Book
Value
|
||||||||||
|
Laboratory equipment, computers & software
|
$
|
48,152
|
$
|
38,285
|
$
|
9,867
|
||||||
|
Office furniture
|
10,819
|
5,695
|
5,164
|
|||||||||
|
Automobiles
|
28,800
|
17,872
|
10,928
|
|||||||||
|
$
|
87,771
|
$
|
61,812
|
$
|
25,959
|
|||||||
|
August 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Solde Naprodis Inc.
|
$
|
-
|
$
|
3,198
|
||||
|
Phybiosis Inc.
|
-
|
120,105
|
||||||
|
Loresys
|
-
|
16,283
|
||||||
|
$
|
-
|
$
|
139,586
|
|||||
|
August 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Paul Petit
|
$
|
-
|
$
|
106,378
|
||||
|
Alain Petit
|
-
|
23,973
|
||||||
|
Kelley Thompson
|
-
|
67,427
|
||||||
|
Jean-Phillipe Petit
|
-
|
5,000
|
||||||
|
Antoine Lagomarsino
|
-
|
6,459
|
||||||
|
Guillaume Petit
|
-
|
7,500
|
||||||
|
$
|
-
|
$
|
216,737
|
|||||
|
●
|
The Company’s former officers and directors resigned and new management was appointed;
|
|
|
●
|
The Company’s former president agreed to the cancellation of 1,175,000 shares of his common stock. These shares were returned to treasury and cancelled;
|
|
|
●
|
A former principal shareholder sold 1,788,000 shares of the Company’s common stock to the Company for a nominal consideration. The shares sold to the Company were returned to treasury and cancelled.
|
|
Name
|
Date
|
Shares
|
Consideration
|
|||||||||
|
Officer and Director
|
11-12-14 | 5,000,000 | $ | 63,000 | (1) | |||||||
|
Director
|
11-12-14 | 5,000,000 | $ | 63,000 | ||||||||
|
Unrelated third party
|
11-25-14 | 3,174,600 | $ | 40,000 | ||||||||
|
(1)
|
Payment was received in August 2014 and recognized on the balance sheet as a stock subscription payable for the value of shares due to be issued.
|
| Date: January 14, 2015 | NAPRODIS, INC. | ||
|
|
By:
|
/s/ Daniel Allen | |
|
Daniel Allen, Principal Executive Officer
|
|||
|
Signature
|
Title
|
Date
|
||
|
/s/ Daniel Allen
|
Principal Executive,
|
January 14, 2015
|
||
|
Daniel Allen
|
Financial and Accounting Officer | |||
| and a Director | ||||
|
/s/ Chase Zeman
|
Director
|
January 14, 2015
|
||
|
Chase Zeman
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|